Peter Hoogerbrugge, PhD Pediatric Oncologist, Prinses Maxima Centrum, Utrecht Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia https://ash.confex.com/ash/2018/webprogram/Paper112599.htmlLees meer
0120HEM1291233
×

Ask Speakers

×

Medical Information Request